Outcome of single fraction total body irradiation-conditioned stem cell transplantation in younger children with malignant disease
Comparison with a busulphan-cyclophosphamide regimen

REFERENCES

• Brochstein JA, Kernan NA, Groschen S, et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukaemia. N Engl J Med 1987; 317: 1618–24.
   PubMed Web of Science ®Google Scholar
• Oakhill A, Pamphilon DH, Potter MN, et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996; 94: 574–8.
   PubMed Web of Science ®Google Scholar
• Saarinen UM, Mellander L, Nysom K, et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukaemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO). Bone Marrow Transplant 1996; 17: 357–63.
   Google Scholar
• Woolfrey AE, Anasetti C, Storer B, et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukaemia in children. Blood 2002; 99: 2002–8.
   PubMed Web of Science ®Google Scholar
• Michel G, Socié G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myelo-blastic leukaemia in first complete remission: the impact of conditioning regimen without total-body irradiation—a report from the Société Francaise de Greffe de Moelle. J Clin Oncol 1997; 15: 2238–46.
   PubMed Web of Science ®Google Scholar
• Hopewell JW. Radiation injury to the central nervous system. Med Pediatr Oncol 1998; (Suppl 1): 1–9.
   Google Scholar
• Bleyer WA. Chemoradiotherapy interactions in the central nervous system. Med Pediatr Oncol 1998; (Suppl 1): 10–16.
   Google Scholar
• Giorgiani G, Bozzola M, Locatelli F, et al. Role of busulphan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86: 825–31.
   PubMed Web of Science ®Google Scholar
• Sanders JE. Endocrine problems in children after bone marrow transplantation for hematological malignancies. Bone Marrow Transplant 1991; 8(Suppl 1): 2–4.
   PubMed Web of Science ®Google Scholar
• Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Pxdiatr 1995; (Suppl 411): 57–61.
   Google Scholar
• Carlson K. Lönnerholm G, Smedmyr B, et al. Thyroid function after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 10: 123–7.
   PubMed Web of Science ®Google Scholar
• Cohen A, Rovelli A, Bakker B, et al. Final height of patients who underwent bone marrow transplantation for hematologi-cal disorders during childhood: a study by the working party for late effects-EBMT. Blood 1999; 93: 4109–15.
   PubMed Web of Science ®Google Scholar
• Holmstrom G, Borgstrom B, Calissendorff B. Cataract in children after bone marrow transplantation: relation to con-ditioning regimen. Acta Ophthalmol Scand 2002; 80: 211–5.
   Google Scholar
• Ringden 0, Labopin M, Tura S, et al. A comparison of busulphan versus total body irradiation combined with cyclo-phosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Br J Haematol 1996; 93: 637–45.
   Google Scholar
• Ringden O, Remberger M, Ruutu T, et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulphan versus total body irradiation: long-term results of a randomised trial in allogeneic marrow recipients with leukemia. Blood 1999; 93: 2196–201.
   Google Scholar
• Favre C, Nardi M, Dini G, et al. The role of total body irradiation (TBI). Bone Marrow Transplant 1996; 18(Suppl 2): 71–4.
   PubMed Web of Science ®Google Scholar
• Davies SM, Ramsay NKC, Klein JP, et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukaemia. J Clin Oncol 2000; 18: 340–7.
   PubMed Web of Science ®Google Scholar
• Deeg HJ, Sullivan KM, Buckner CD, et al. Marrow transplan-tation for acute non-lymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1986; 1: 151–7.
   PubMed Web of Science ®Google Scholar
• Socie G, Devergie A, Girinsky T, et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. Int J Radiat Oncol Biol Phys 1991; 20: 397–404.
   PubMed Web of Science ®Google Scholar
• Appelbaum FR. The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation. Semin Oncol 1993; 20(Suppl 4): 3–10.
   PubMed Web of Science ®Google Scholar
• Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.
   PubMed Web of Science ®Google Scholar
• Socié G, Clift RA, Blaise D, et al. Busulphan plus cyclopho-sphamide compared with total-body irradiation plus cyclopho-sphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569–74.
   Google Scholar
• Bacigalupo A, Lamparelli T, Gualandi F, et al. Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: a 10-year follow-up of a randomized study. Blood 2001; 98: 3174–5.
   PubMed Web of Science ®Google Scholar
• Uzunel M, Mattson J, Jaksch M, Remberger M, Ringden 0. The significance of graft-versus-host disease and pretransplan-tation minimal residual disease status to outcome after allogeneic stem cell transplantation patients with acute lym-phoblastic leukemia. Blood 2001; 98: 1982–4.
   Google Scholar